SCHEMBL6710141

SCHEMBL6710141

O=C(Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.44
STK33 Q9BYT3 2/20 0.43
SERPINE1 P05121 4/20 0.43
PLCG2 P16885 1/20 0.43
NHERF1 O14745 3/20 0.42
KCNMA1 Q12791 1/20 0.42
AKR1C4 P17516 1/20 0.41
AKR1C3 P42330 1/20 0.41
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
NSD2 O96028 1/20 0.41
PRSS12 P56730 1/20 0.40
EGFR P00533 1/20 0.40
PIK3CA P42336 1/20 0.40
PLA2G7 Q13093 1/20 0.40
KDM4E B2RXH2 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
ACHE P22303 1/20 0.39
MAOB P27338 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713155 0.96 SERPINE1 (0.48) GRIK1STK33SERPINE1PLCG2NHERF1
SCHEMBL6709929 0.93 GRIK1 (0.49) GRIK1STK33PLCG2NHERF1PRSS12
SCHEMBL6713656 0.92 GRIK1 (0.42) GRIK1STK33PLCG2KCNMA1AKR1C4
SCHEMBL6708655 0.92 NHERF1 (0.46) GRIK1STK33PLCG2NHERF1EGFR
SCHEMBL6709173 0.91 GRIK1 (0.44) GRIK1STK33PLCG2NHERF1NSD2
SCHEMBL6709991 0.91 KDR (0.44) GRIK1STK33PLCG2NHERF1PLA2G7
SCHEMBL6710389 0.90 MEN1 (0.40) GRIK1STK33PLCG2AKR1C4AKR1C3
SCHEMBL6712018 0.90 CHRNB2 (0.42) GRIK1STK33SERPINE1PLCG2NHERF1
SCHEMBL6709861 0.90 GRIK1 (0.41) GRIK1PLCG2NHERF1NSD2KDM4E
SCHEMBL6707858 0.90 MEN1 (0.47) GRIK1PLCG2RXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885STK33 3606/4885SERPINE1 2108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.